TRANS1 INC
			Symbol			TSON

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

TranS1 Inc. Schedules Third Quarter 2009 Earnings Release and Conference Call for Thursday, October 29, 2009

2009-10-23 17:30 ET - News Release

WILMINGTON, N.C., Oct. 23, 2009 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release third quarter 2009 financial results after market close on Thursday, October 29, 2009. Rick Randall, President and Chief Executive Officer of TranS1, and Mike Luetkemeyer, Chief Financial Officer, will host a conference call starting at 5:30 pm ET on the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial 888-298-3490 for domestic callers and 719-325-2174 for international callers approximately ten minutes prior to the start time. To access the live audio broadcast or the subsequent archived recording, visit the TranS1 Web site at http://www.trans1.com under the investor relations section.

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine. TranS1 currently markets two single-level fusion products, the AxiaLIF(R) and the AxiaLIF 360(TM), and a two-level fusion product, the AxiaLIF 2L(TM), in the U.S. and Europe. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.